Event header image

Nordic-Baltic Conference in Clinical Trials 2024

8th Nordic-Baltic Clinical Trials Conference – How to boost clinical research in the Nordic and Baltic Region?

 

The program is presented in Helsinki time. 

 

Day 1: 30.10.2024

 

12.15-13.00 Registration, networking and lunch

 

13.00-13.10 Welcome and practicalities

Ouli Uimonen, CEO, Pharmaca Health Intelligence Oy
Mia Bengtström, Associate Professor, Åbo Akademi University 

Chair: Jutta Lindborg, Head Customer and Study Engagement EMEA & LATAM 4, Bayer Oy

 

EU actions to boost the competitiveness of EU in clinical trials 

13.10-13.40 Accelerating Clinical Trials in the EU (ACT EU) with focus on Priority Action 8 that aims to facilitate the development of aligned clinical trial guidance across the EU

Monique Al, Vice Chair, Clinical Trials Coordination Group (CTCG) and Special Advisor, Central Committee on Research Involving Human Subjects (CCMO), the Netherlands

 

13.40-14.15 Decentralised clinical trials and ICH GCP for the future of clinical trials

Tiina Holmberg, Senior Inspector Fimea, Seconded National Expert EMA

 

What is needed to get more clinical trials to EU and the Nordic / Baltic Region?

14.15-14.40 What are Pharma companies looking for when placing clinical trials? What does it take to become an attractive country?

Eva Adås, Nordic head clinical operation at Johnson&Johnson Innovative Medicine

14.40-15.05 What is needed for Academic clinical trials to flourish?

Raija Silvennoinen, Senior Hematologist, Helsinki University Hospital Comprehensive Cancer Center

 

15.05-15.35 Coffee Break

 

Attracting clinical trials by Ethics Committee collaboration to achieve harmonized requirements

15.35-16.00 MedEthicsEU 

Monique Al, Special Advisor, Central Committee on Research Involving Human Subjects (CCMO), the Netherlands

16.00-16.20 Reflections on how the Nordic and Baltic Region can promote harmonization

Outi Konttinen, General secretary, National Committee on Medical Research Ethics (Tukija)

 

Cross Border Clinical trials – why are they so important? 

16.20-16.45 Cross Border clinical trials, what is it and why is it a problem? The EU-X-CT initiative

Susan Bhatti, EU Global Regulatory and Scientific Policy, Merck B.V.

16.45-17.10 Overcoming issues related to cross border participation will benefit patients and make Europe a more attractive place for clinical trials 

Bettina Ryll, Stockholm School of Economics Institute for Research, Melanoma Patients Network Europe

17.10-17.15 Thank you for today and practicalities

18.00-19.00 Networking Event hosted by the City of Helsinki at the Old City Hall

 

 

Day 2: 31.10.2024

Actions to boost the competitiveness of the Nordic and Baltic region in clinical trials and trends in clinical trials

 

8.30 Registration and light breakfast for on-site participants

 

9.00- 9.10 Introduction to day 2

Chair: Catharina Östberg, Clinical Operations Head of Site Management Hub EMEA 1, Bayer

 

National strategies and best practices

9.10-9.25 Actions in Finland to improve the competitiveness of clinical trials
Päivi Sillanaukee, Special Envoy for Health and Well-being, Ministry of Social Affairs and Health


9.25-9.40 Trial Nation – Denmark
Kirsten Bødker, Head of Business Relations, Trial Nation


9.40-9.55 NorTrials – Norway
Signe Øien Fretland, Head of NorTrials coordinating unit, Oslo University Hospital


9.55-10.10 Clinical Studies Sweden
Anna Ramnemark, Chairman of Clinical Studies Sweden, Head of Clinical Research Center, Umeå


10.10-10.30 Actions in Sweden to improve the competitiveness of clinical trials
Gunilla Andrew-Nielsen, Head of Clinical Trials and Special Permissions, MPA


10.30-10.45 The information of recruiting clinical trials – for patients and treating physicians
Kaisa Sunela, Head of section, Clinical assessor/chief physician, Fimea

 

10.45-11.15 Discussions on Nordic-Baltic collaboration and some examples

moderator: Catharina Östberg

Panelists: Päivi Sillanaukee, Kirsten Bødker, Signe Øien Fretland, Anna Ramnemark, Gunilla Andrew-Nielsen, Kaisa Sunela

 

11.15-12.30 Lunch

 

Medicines-Device combination trials

12.30-13.10 EU commission initiative COMBINE

Janica Juvonen, Senior officer, National Committee on Medical Research Ethics

 

Boosting clinical research

13.10-13.45 Panel discussion: How to boost clinical research in the Nordic and Baltic Region? 


Gunilla Andrew-Nielsen, Catharina Östberg, Charlotte Qwist, Mika Scheinin, Katriina Jalkanen, Bettina Ryll

 

13.45-14.15 Networking Coffee

 

14.15-14.45 Drug Rediscovery Protocol (DRUP) study FINPROVE and collaboration in Personalized cancer care in EU

Katriina Jalkanen, Head Physician, HUS Comprehensive Cancer Center, Clinical Trial Unit

14.45-15.10 Value from Nordic Health Data VALO - Better research, development and innovations within Nordics

Markus Kalliola, Programme Director, Sitra

 

15.10-15.30 National clinical trials awards 2024 

The researcher of the year

The research nurse of the year

The CRA of the year

 

15.30 Thank you for participating in the Nordic and Baltic collaborative conference!

Select number of registrations
Registration
Registration ends
Price
Amount

Registration ends 31.12.2024 23:59
595,00 € (excl. VAT 25.5%)

Amount:


Registration ends 31.12.2024 23:59
595,00 €

Amount:


Contact us

 

saana-kuva.png

Saana Lehmussari

Training producer

academy@pharmaca.fi

+358 9 6150 4973

 

A larger group or unlimited access?

Ask for an offer here

 

Event partners

medfiles_logo_valkoinenm_png-id-59046-002.png

granitics-ecrf.jpg

labquality-logo.png

 

Interested in partnership?

Ask us about visibility and partnership options here